H1N1 Swine Flu Vaccines (cont.)
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
In this Article
- What is the 2009 H1NI (swine flu) vaccine?
- How are the H1N1 vaccines manufactured and are they safe?
- What are the differences between the H1N1 and regular flu vaccine?
- Who should receive H1N1 flu vaccine?
- What is the influenza A (H1N1) 2009 monovalent vaccine (inactivated injectable)
- What are risks of adverse events and side effects for the influenza A (H1N1) 2009 monovalent vaccine (inactivated injectable)?
- Who should receive more than one dose of the monovalent vaccine (inactivated injectable) and what about pregnant or nursing women?
- What is the influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
- Who should and should not receive the influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
- What are the side effects of the influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
- Who should receive more than one dose of the vaccine influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
Who should receive more than one dose of the vaccine influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
Individuals older than 10 years of age should receive a single shot while children nine years old and younger may require two shots one month apart. Injectable H1N1 vaccine may be adminstered to pregnant or breastfeeding women and also may be administered with other vaccines.
What is the influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
The nasal spray vaccine is made with live, weakened viruses that cannot grow at normal body temperature. The H1N1 nasal spray vaccine is manufactured by MedImmune in the same way as the seasonal nasal spray vaccine (Flumist), but instead of containing three weakened live flu viruses, it contains weakened 2009 H1N1 flu virus.
Who should and should not receive the influenza A (H1N1) 2009 monovalent vaccine (live, intranasal spray)?
Intranasal flu vaccine is used for prevention of the flu caused by H1N1 virus in healthy individuals 2 to 49 years of age. It should not be administered to people younger than 2 years or older than 50 years; pregnant women; those with chronic illnesses (for example, chronic heart or lung disease, diabetes or kidney failure); people with reduced immune function, or taking medications that weaken the immune system; and individuals allergic to chicken eggs or any of the components of the vaccine.
References:
CDC Questions & Answers: 2009 H1N1 Nasal Spray Vaccine
Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Limited), Prescribing Information
Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc.), Prescribing Information
Influenza A (H1N1) 2009 Monovalent Vaccine (CSL Limited), Prescribing Information
Women's Health
Find out what women really need.
Updated & New
